← FDA ENFORCEMENT
D-0365-2024Class III

Contract Pharmaceuticals Limited Canada

Recalling firm
Contract Pharmaceuticals Limited Canada
Product type
Drug
Status
Ongoing
Report date
2024-03-13
Distribution
Nationwide in the U.S. and Puerto Rico
Product quantity
11,750 bottles
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & Qualification
Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Product description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Code / lot info

Lot #: 119874; Exp 06/30/2025

Other recalls SPEQ maps to Validation & Qualification
2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc
See all Validation & Qualification recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.